Tauopathies are typically classified into primary and secondary tauopathies based on the molecular composition of tau aggregates and the co‐occurrence of other protein deposits, such as beta amyloid plaque pathology in Alzheimer's disease (AD). The gene discussed is MAPT; the disease is tauopathy.